Covid-19 nasal vaccine gets emergency use authorisation
Telangana
By Sumit Jha
November 29, 2022
Read the article
Hyderabad-based Bharat Biotech announced that its Covid-19 nasal vaccine iNCOVACC had
received approval.
Telangana
Read the article
The Central Drugs Standard Control Organisation has approved it under Restricted Use in Emergency Situation for booster doses.
Telangana
Read the article
According to Bharat Biotech, the nasal delivery system has been designed and developed to be
cost-effective
in
low- and middle-income countries.
Telangana
Read the article
The company continued product development despite the lack of demand for
Covid-19 vaccines
to ensure preparedness for future diseases.
Telangana
Read the article
iNCOVACC has the double benefit of enabling faster development of variant-specific vaccines and easy nasal delivery.
Telangana
Read the article
This enables mass immunisation which can make it an important tool in mass vaccinations
during pandemics
and endemics.
Telangana
Read the article
iNCOVACC is stable at 2-8° C for easy storage and distribution.
Telangana
Read the article
Bharat Biotech said it has established large manufacturing capabilities at multiple sites across India.
Telangana
Read the article
The vaccine was developed in partnership with Washington University, St Louis and funded in part by the Central government.
Telangana
Read the article